EZH2 and cancer: In squamous cell carcinoma, enhancer of zeste homolog 2 (EZH2) inhibits RUNX3 (RUNX Family Transcription Factor 3) expression to activate both SETDB1 and ΔNp63α, which drives an aggressive cancer stem cell phenotype [97].